Role evidence
Usage summary
Strongest role: Inclusion Required
Inclusion-required count: 2
Treatment-assignment count: 0
Stratification count: 0
Trial Selection Rising
FGFR2 fusion
solid tumor basket · Therapy Not Normalized
FGFR2 fusion is flagged as trial selection rising because public trials show inclusion required evidence in 4 contexts. FDA CDx context should be reviewed manually.
Threshold snippets
Fragmentation view
Threshold count: 2
Common snippets: MSI-H | BRAF V600E
Threshold label: Moderate
FDA CDx context
Mapping summary
CDx label: Fda Cdx Context Not Found
CDx maturity score: 1/5
Confidence: High
Patent-density signal
Diagnostic appendix
Signal count: 0
Recent signals: 0
Density label: Low
Source links
Evidence paths
https://clinicaltrials.gov/study/NCT07259889 | https://clinicaltrials.gov/study/NCT06656390 | https://clinicaltrials.gov/study/NCT02265341 | https://clinicaltrials.gov/study/NCT03155620